Results 171 to 180 of about 55,907 (261)

Perspectives for Advancing Biotechnological Succinic Acid Production

open access: yesMicrobial Biotechnology, Volume 19, Issue 5, May 2026.
Succinic acid is an important molecule for sustainable chemical manufacturing, but its industrial production faces high costs and sustainability challenges, which are linked to feedstocks and excessive acid/base consumption. This opinion explores production routes based on next‐generation feedstocks and low‐pH fermentations to inspire novel cost ...
Christoph Gunkel, Bastian Blombach
wiley   +1 more source

Genetic biomarker for SMN

open access: yes
Report comparing SNP in patients with primary and secondary cancers.
openaire   +1 more source

Biodegradable film: a sustainable alternative to polyethylene film for Loess Plateau maize production. [PDF]

open access: yesFront Plant Sci
Sun X   +8 more
europepmc   +1 more source

Optimizing Oligonucleotide Therapeutics: A Model‐Informed Drug Development Perspective

open access: yesClinical and Translational Science, Volume 19, Issue 5, May 2026.
ABSTRACT Oligonucleotide therapies have emerged as a powerful therapeutic class, providing novel solutions for diverse diseases through antisense oligonucleotides (ASOs), small interfering RNAs (siRNAs), and aptamers that specifically target and modulate gene expression or protein function. However, oligonucleotide development faces distinct challenges,
Ye Yuan   +7 more
wiley   +1 more source

Expressive language and social communication abilities in children with spinal muscular atrophy type 1

open access: yesDevelopmental Medicine &Child Neurology, Volume 68, Issue 5, Page 696-705, May 2026.
Abstract Aim To investigate parent‐reported expressive language and social communication abilities in children with spinal muscular atrophy type 1 (SMA1) treated with disease‐modifying therapies. Method This was a cross‐sectional feasibility study performed at the Dubowitz Neuromuscular Centre, London (UK), and the Centro Clinico Nemo Pediatrico, Rome (
Chiara Brusa   +19 more
wiley   +1 more source

Subsequent Neoplasm Risk After Modern Mediastinal Radiation Therapy for Pediatric Hodgkin Lymphoma: Insights From a Multi-Institutional Children's Oncology Group Trial. [PDF]

open access: yesInt J Radiat Oncol Biol Phys
Milgrom SA   +16 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy